20-20 Investing

08/03/2018

Nice overview of checkpoint inhibitors....

Immunotherapy comes with a unique set of side effects.

01/20/2018

Free Biotech Investing for Beginners eBookSnapshot of biotech companies from the large pharmas to the small micro-capsOverview of the FDA approval processCase studies of large stock price moves and what caused themHow the 20-20 Investing App can help investors keep track of this biotech industry inf...

12/30/2017

Good summary of various treatment options...

12/10/2017

CAR-T therapies from Novartis, Bluebird Bio, and Gilead Sciences show long-lasting effectiveness at halting cancer progression in some patients.

11/21/2017

Juno Therapeutics says it is developing a safer T-cell therapy

10/27/2017

Wiring cells to kill cancer takes a month and requires a team of 150 doctors, nurses, scientists, and couriers. But it could revolutionize treatment.

10/21/2017

Gilead's $12B Bet Pays Off in Two Months After the FDA Approves Kite's Revolutionary CAR-T Therapy - read this article along with other careers information, tips and advice on BioSpace

08/30/2017

The FDA has approved our CAR-T cell therapy. Learn more: http://bit.ly/2wSChL7

08/28/2017

$KITE news has other CAR-T stocks up as well. $JUNO $BLUE $CLLS

The big biotech, long under pressure to make a deal, is using part of its cash stockpile to pick up the hot CAR-T company. 

08/23/2017

Cancer immunotherapy biomarkers The immune system can help protect the body against cancer by sending T cells to attack tumour cells. However, tumour cells can produce a protein called programmed death-ligand 1 (PD-L1), enabling cancers to evade the immune system.1,2   PD-L1 works like a ‘stop sign’...

07/19/2017

LOS ANGELES – Shares of Puma Biotechnology (PBYI) are up nearly 12 percent this morning after the U.S. Food and Drug Administration (FDA) approved...

07/19/2017

Today we announced our second quarter results. Learn more: http://bit.ly/2tkYUGt